---
title: "Ispecimen Inc - Annual Meeting Repeatedly Adjourned For Lack Of Quorum - SEC Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282590515.md"
datetime: "2026-04-13T21:03:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282590515.md)
  - [en](https://longbridge.com/en/news/282590515.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282590515.md)
---

# Ispecimen Inc - Annual Meeting Repeatedly Adjourned For Lack Of Quorum - SEC Filing

April 13 (Reuters) - iSpecimen Inc (ISPC.O) : \* ISPECIMEN INC - ANNUAL MEETING REPEATEDLY ADJOURNED FOR LACK OF QUORUM - SEC FILING \* ISPECIMEN INC - TO RECONVENE ANNUAL MEETING ON MAY 8, 2026 - SEC FILING Source text: \[\] Further company coverage: (ISPC.O)

### Related Stocks

- [ISPC.US](https://longbridge.com/en/quote/ISPC.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)

## Related News & Research

- [Genflow Advances SIRT6 Longevity Pipeline as Funding and Canine Trial Progress Bolster Position](https://longbridge.com/en/news/284772118.md)
- [Guardant Health, Inc. $GH Position Trimmed by Jennison Associates LLC](https://longbridge.com/en/news/284787942.md)
- [Illumina Q1 revenue beats on demand for NovaSeq X](https://longbridge.com/en/news/284828330.md)
- [Summit's Q1 Net Loss Widens; Expects Patient Enrollment In Phase III ILLUMINE Study In Q2,2026](https://longbridge.com/en/news/284871928.md)
- [Erasca Shares Phase 1 ERAS-0015 Data: 62% NSCLC Response, ctDNA Clearance Signals](https://longbridge.com/en/news/284275878.md)